Search

Author/Creator Mweemba, Aggrey

1. COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021–2022. (11th September 2022)

Authors:
Chanda, Duncan; Hines, Jonas Z; Itoh, Megumi; Fwoloshi, Sombo; Minchella, Peter A; Zyambo, Khozya D; Sivile, Suilanji; Kampamba, Davies; Chirwa, Bob; Chanda, Raphael; Mutengo, Katongo; Kayembe, Mazinga F; Chewe, Webster; Chipimo, Peter; Mweemba, Aggrey; Agolory, Simon; Mulenga, Lloyd B
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Elevated AST‐to‐platelet ratio index is associated with increased all‐cause mortality among HIV‐infected adults in Zambia. (22nd January 2015)

Authors:
Vinikoor, Michael J.; Sinkala, Edford; Mweemba, Aggrey; Zanolini, Arianna; Mulenga, Lloyd; Sikazwe, Izukanji; Fried, Michael W.; Eron, Joseph J.; Wandeler, Gilles; Chi, Benjamin H.
Journal:
Liver international
Issue:
Volume 35:Number 7(2015:Jul.)
Page Start:
1886
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Issue 1 (January 2018)

Authors:
Hakim, James G; Thompson, Jennifer; Kityo, Cissy; Hoppe, Anne; Kambugu, Andrew; van Oosterhout, Joep J; Lugemwa, Abbas; Siika, Abraham; Mwebaze, Raymond; Mweemba, Aggrey; Abongomera, George; Thomason, Margaret J; Easterbrook, Philippa; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I; Agweng, ...
Journal:
Lancet infectious diseases
Issue:
Volume 18:Issue 1(2018)
Page Start:
47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Issue 1 (January 2018)

Authors:
Hakim, James G; Thompson, Jennifer; Kityo, Cissy; Hoppe, Anne; Kambugu, Andrew; van Oosterhout, Joep J; Lugemwa, Abbas; Siika, Abraham; Mwebaze, Raymond; Mweemba, Aggrey; Abongomera, George; Thomason, Margaret J; Easterbrook, Philippa; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I
Journal:
Lancet infectious diseases
Issue:
Volume 18:Issue 1(2018)
Page Start:
47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey. Issue 6 (June 2021)

Authors:
Mulenga, Lloyd B; Hines, Jonas Z; Fwoloshi, Sombo; Chirwa, Lameck; Siwingwa, Mpanji; Yingst, Samuel; Wolkon, Adam; Barradas, Danielle T; Favaloro, Jennifer; Zulu, James E; Banda, Dabwitso; Nikoi, Kotey I; Kampamba, Davies; Banda, Ngawo; Chilopa, Batista; Hanunka, Brave; Stevens, Thomas L; Shibemb...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2021)
Page Start:
e773
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers—Zambia, July 2020. (30th March 2021)

Authors:
Fwoloshi, Sombo; Hines, Jonas Z; Barradas, Danielle T; Yingst, Samuel; Siwingwa, Mpanji; Chirwa, Lameck; Zulu, James E; Banda, Dabwitso; Wolkon, Adam; Nikoi, Kotey I; Chirwa, Bob; Kampamba, Davies; Shibemba, Aaron; Sivile, Suilanji; Zyambo, Khozya D; Chanda, Duncan; Mupeta, Francis; Kapina, Muzal...
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 6(2021)
Page Start:
e1321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗